Clinical Trial Update: Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating lenalidomide and dexamethasone with or without thalidomide in patients with multiple myeloma (stages I–III).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• Thalidomide (thalidomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: DS Stage I Multiple Myeloma, DS Stage II Multiple Myeloma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2014-01-22